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SCIENTIFIC LETTERS
Elizabeth Wasserman, Associate Professor and Chairperson,
Department of Medical Microbiology, National Health
Laboratory Service, Coastal Branch, and Stellenbosch
University, comments: Tick-borne diseases are common and
serious, yet we know relatively little about their causative
agents, epidemiology and pathogenesis in South Africa. We are
familiar with the typical clinical presentation of tick-bite fever,
but it is difficult to confirm the causative agent in the routine
laboratory. Serology for rickettsial infection often remains
negative, even late in the disease, and the polymerase chain
reation (PCR), offered at many laboratories, lacks sensitivity.
Our knowledge of the so-called ‘African tick-bite fever’ caused
by Rickettsia africae and transmitted by Amblyomma ticks
originates mostly from cases reported from Europe in which
the disease was contracted while travelling in sub-Saharan
Africa. 
Human ehrlichiosis (caused by Ehrlichia chafeensis and E.
ewingii) is well described and frequently reported in the USA.1
Ehrlichiosis is often associated with mild to severe disease,2
with a mortality ranging from 2% to 3%, including healthy
children. E. ruminantium and its Amblyomma vectors have an
indiscriminate host range3 and human disease is therefore
conceivable. 
Many questions regarding the aetiology and epidemiology of
tick-borne disease in South Africa remain unanswered and
require further study. 
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To the Editor: We report on patients with ocular rhinospori-
diosis who attended the eye clinic at Umtata General Hospital.
No previous cases have been reported in the Xhosa-speaking
population.
Conjunctival rhinosporidiosis is a rare infectious disease that
typically occurs in young people. It was first described as a
pathogen in humans a century ago.1 The aetiological agent,
Rhinosporidium seeberi, commonly produces granulomatous
inflammation of the affected mucosa. Most reported ocular
infections have occurred in hot, dry climatic regions.2 The
diagnosis is usually made by biopsy and treatment is by
surgical excision. In South Africa cases have been reported
from KwaZulu-Natal.3,4
Material and methods
We reviewed medical records from January 1997 to December
2003 of patients treated at the eye clinic at Umtata General
Hospital with histopathological confirmation of
rhinosporidiosis. Six patients with rhinosporidiosis were
identified during this period. 
All our patients were of Xhosa origin. Three males and 3
females were affected. All were under the age of 15 years; 
1 was below the age of 5 years, 4 were between the ages 5 and
10 years, and 1 was above the age of 10 years. 
All patients presented with muco-purulent discharge from
the affected eyes and most also presented with a conjunctival
polypoid mass. One patient showed conjunctival chemosis and
1 presented with bleeding from the affected eye. No associated
nasal affection was seen in these patients. In keeping with
findings elsewhere, none of the cases was diagnosed clinically
as rhinosporidiosis.5
These lesions did not respond to antibiotic and anti-
inflammatory treatment. All were treated by surgical excision,
following which there were no recurrences and the patients
were asymptomatic. 
In all our patients there was conjunctival localisation, with
typically chronic non-granulomatous inflammation.
Histologically all stages of the organism’s life cycle could be
found in the excised tissue, from small trophocytes to large
sporangia-containing sporoblasts6 (Fig. 1).
Discussion
The conjunctival lesion of rhinosporidiosis was first described
in India in 1912.7 It is endemic in India, Sri Lanka and parts of
East Africa and South America and is caused by R. seeberi, an
endosporulating micro-organism.8 Although conjunctival
rhinosporidiosis is an infectious disease rarely recorded outside
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the Indian subcontinent, it is seen on the African continent
mainly in Malawi, Kenya, Uganda and Congo.9 Increased
migration to the West of persons who acquired
rhinosporidiosis in their native Asian countries has resulted in
increasing occurrence of this disease in the West.10
Varying male-to-female ratios have been reported.11-13
No other family members were involved among our patients
and no transmission between members of the same family has
ever been documented.  The presumed mode of infection from
the natural aquatic habitat of R. seeberi is through the
traumatised epithelium, most commonly via nasal sites, but
also via the external urethral meatus, the conjunctiva or the
skin.14
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Fig. 1, above and below. All stages of the organism’s life cycle can be
seen in the excised tissue, from small trophocytes to large sporangia-
containing sporoblasts.
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